
Revolutionizing Alzheimer’s Care: LEQEMBI® IQLIKTM Autoinjector Makes TIME’s List for 2025
A Milestone in Alzheimer’s Treatment The inclusion of LEQEMBI® IQLIKTM (Lecanemab-Irmb) Subcutaneous Autoinjector in TIME’s “Best Inventions of 2025” represents a significant leap forward in the care and management of Alzheimer’s disease. This innovative device simplifies the administration of treatment for patients, allowing for self-injection in familiar settings, thus promoting adherence to prescribed therapies and…



